3 research outputs found
Accurate and Efficient Bypass of 8,5′-Cyclopurine-2′-Deoxynucleosides by Human and Yeast DNA Polymerase η
Reactive oxygen species (ROS), which can be produced
during normal
aerobic metabolism, can induce the formation of tandem DNA lesions,
including 8,5′-cyclo-2′-deoxyadenosine (cyclo-dA) and
8,5′-cyclo-2′-deoxyguanosine (cyclo-dG). Previous studies
have shown that cyclo-dA and cyclo-dG accumulate in cells and can
block mammalian RNA polymerase II and replicative DNA polymerases.
Here, we used primer extension and steady-state kinetic assays to
examine the efficiency and fidelity for polymerase η to insert
nucleotides opposite, and extend primer past, these cyclopurine lesions.
We found that <i>Saccharomyces cerevisiae</i> and human
polymerase η inserted 2′-deoxynucleotides opposite cyclo-dA,
cyclo-dG and their adjacent 5′ nucleosides at fidelities and
efficiencies that were similar to those of their respective undamaged
nucleosides. Moreover, the yeast enzyme exhibited similar processivity
in DNA synthesis on templates housing a cyclo-dA or cyclo-dG to those
carrying an unmodified dA or dG; the human polymerase, however, dissociated
from the primer–template complex after inserting one or two
additional nucleotides after the lesion. Pol η’s accurate
and efficient bypass of cyclo-dA and cyclo-dG indicates that this
polymerase is likely responsible for error-free bypass of these lesions,
whereas mutagenic bypass of these lesions may involve other translesion
synthesis DNA polymerases. Together, our results suggested that pol
η may have an additional function in cells, i.e., to alleviate
the cellular burden of endogenously induced DNA lesions, including
cyclo-dA and cyclo-dG
Quantification of Azaserine-Induced Carboxymethylated and Methylated DNA Lesions in Cells by Nanoflow Liquid Chromatography-Nanoelectrospray Ionization Tandem Mass Spectrometry Coupled with the Stable Isotope-Dilution Method
Humans
are exposed to <i>N</i>-nitroso compounds through
environmental exposure and endogenous metabolism. Some <i>N</i>-nitroso compounds can be metabolically activated to yield diazoacetate,
which is known to induce DNA carboxymethylation. DNA lesion measurement
remains one of the core tasks in toxicology and in evaluating human
health risks associated with carcinogen exposure. In this study, we
developed a highly sensitive nanoflow liquid chromatography-nanoelectrospray
ionization-multistage tandem mass spectrometry (nLC-nESI-MS<sup>3</sup>) method for the simultaneous quantification of <i>O</i><sup>6</sup>-carboxymethyl-2′-deoxyguanosine (<i>O</i><sup>6</sup>-CMdG), <i>O</i><sup>6</sup>-methyl-2′-deoxyguanosine
(<i>O</i><sup>6</sup>-MedG), and <i>N</i><sup>6</sup>-carboxymethyl-2′-deoxyadenosine (<i>N</i><sup>6</sup>-CMdA). We were able to measure the levels of these three
lesions with the use of low-microgram quantities of DNA from cultured
human skin fibroblasts and human colorectal carcinoma cells treated
with azaserine, a DNA carboxymethylating agent. Our results revealed
that the levels of <i>O</i><sup>6</sup>-CMdG and <i>O</i><sup>6</sup>-MedG increased when the dose of azaserine
was increased from 0 to 450 μM. We, however, did not observe
an apparent dose-dependent induction of <i>N</i><sup>6</sup>-CMdA, suggesting the presence of repair mechanism(s) for the rapid
clearance of this lesion in cells. This is the first report about
the application of nLC-nESI-MS<sup>3</sup> technique for the simultaneous
quantification of <i>O</i><sup>6</sup>-CMdG, <i>O</i><sup>6</sup>-MedG, and <i>N</i><sup>6</sup>-CMdA. The method
reported here will be useful for future investigations about the repair
of the carboxymethylated DNA lesions and about the implications of
these lesions in carcinogenesis
<i>In-Vitro</i> Replication Studies on <i>O</i><sup>2</sup>‑Methylthymidine and <i>O</i><sup>4</sup>‑Methylthymidine
<i>O</i><sup>2</sup>- and <i>O</i><sup>4</sup>-methylthymidine (<i>O</i><sup>2</sup>-MdT
and <i>O</i><sup>4</sup>-MdT) can be induced in tissues
of laboratory
animals exposed with <i>N</i>-methyl-<i>N</i>-nitrosourea,
a known carcinogen. These two <i>O</i>-methylated DNA adducts
have been shown to be poorly repaired and may contribute to the mutations
arising from exposure to DNA methylating agents. Here, <i>in
vitro</i> replication studies with duplex DNA substrates containing
site-specifically incorporated <i>O</i><sup>2</sup>-MdT
and <i>O</i><sup>4</sup>-MdT showed that both lesions blocked
DNA synthesis mediated by three different DNA polymerases, including
the exonuclease-free Klenow fragment of <i>Escherichia coli</i> DNA polymerase I (Kf<sup>–</sup>), human DNA polymerase κ
(pol κ), and <i>Saccharomyces cerevisiae</i> DNA polymerase
η (pol η). Results from steady-state kinetic measurements
and LC-MS/MS analysis of primer extension products revealed that Kf<sup>–</sup> and pol η preferentially incorporated the correct
nucleotide (dAMP) opposite <i>O</i><sup>2</sup>-MdT, while <i>O</i><sup>4</sup>-MdT primarily directed dGMP misincorporation.
While steady-state kinetic experiments showed that pol κ-mediated
nucleotide insertion opposite <i>O</i><sup>2</sup>-MdT and <i>O</i><sup>4</sup>-MdT is highly promiscuous, LC-MS/MS analysis
of primer extension products demonstrated that pol κ favorably
incorporated the incorrect dGMP opposite both lesions. Our results
underscored the limitation of the steady-state kinetic assay in determining
how DNA lesions compromise DNA replication <i>in vitro</i>. In addition, the results from our study revealed that, if left
unrepaired, <i>O</i>-methylated thymidine lesions may constitute
important sources of nucleobase substitutions emanating from exposure
to alkylating agents